{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:31Z","timestamp":1787022811323,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>GH insensitivity (GHI) is characterised by short stature, IGF-1 deficiency and normal\/elevated serum GH. IGF-1 insensitivity results in pre- and post-natal growth failure with normal\/high IGF-1 levels. The prevalence of genetic defects is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify the underlying genetic diagnoses in a paediatric cohort with GH or IGF-1 insensitivity using candidate gene (CGS) and whole-exome sequencing (WES) and assess factors associated with the discovery of a genetic defect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We undertook a prospective study of 132 patients with short stature and suspected GH or IGF-1 insensitivity referred to our centre for genetic analysis. 107 (96 GHI, 88 probands; 11 IGF-1 insensitivity, 9 probands) underwent CGS. WES was performed in those with no defined genetic aetiology following CGS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A genetic diagnosis was discovered 38\/107 (36%) patients (32% probands) by CGS. WES revealed 11 patients with genetic variants in genes known to cause short stature. A further 2 patients had hypomethylation in the H19\/IGF2 region or mUPD7 consistent with Silver\u2013Russell Syndrome (total with genetic diagnosis 51\/107, 48% or 41\/97, 42% probands). WES also identified homozygous putative variants in\n                      <jats:italic>FANCA<\/jats:italic>\n                      and\n                      <jats:italic>PHKB<\/jats:italic>\n                      in 2 patients. Low height SDS and consanguinity were highly predictive for identifying a genetic defect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Comprehensive genetic testing confirms the genetic heterogeneity of GH\/IGF-1 insensitivity and successfully identified the genetic aetiology in a significant proportion of cases. WES is rapid and may isolate genetic variants that have been missed by traditional clinically driven genetic testing. This emphasises the benefits of specialist diagnostic centres.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-17-0453","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T20:25:33Z","timestamp":1504556733000},"page":"485-501","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":32,"title":["Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity"],"prefix":"10.1093","volume":"177","author":[{"given":"Lucy","family":"Shapiro","sequence":"first","affiliation":[{"name":"1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina G","family":"Ramadan","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics and Endocrinology Unit, Sabah Hospital, Safat, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate M","family":"Davies","sequence":"additional","affiliation":[{"name":"1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin O","family":"Savage","sequence":"additional","affiliation":[{"name":"1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A","family":"Metherell","sequence":"additional","affiliation":[{"name":"1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L","family":"Storr","sequence":"additional","affiliation":[{"name":"1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"ref11","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism","volume":"86","year":"1989","journal-title":"PNAS"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa013100","article-title":"Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene","volume":"350","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","article-title":"Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity","volume":"92","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"ref341","article-title":"Identification of a novel mutation (L229P) in the GHR gene in a cohort of Pakistani patients with growth hormone insensitivity and severe growth retardation","volume":"72","year":"2009","journal-title":"Hormone Research"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40618-014-0195-1","article-title":"Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency","volume":"38","year":"2015","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-14-0541","article-title":"Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation","volume":"172","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/JME-12-0034","article-title":"Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling","volume":"49","year":"2012","journal-title":"Journal of Molecular Endocrinology"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000355404","article-title":"A novel GHR intronic variant, c.266+83G>T, activates a cryptic 5\u2019 splice site causing severe GHR deficiency and classical GH insensitivity syndrome","volume":"80","year":"2013","journal-title":"Hormone Research in Paediatrics"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1210\/er.2010-0023","article-title":"Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity","volume":"32","year":"2011","journal-title":"Endocrine Reviews"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-09-0583","article-title":"Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity","volume":"162","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/humu.1380010105","article-title":"Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome","volume":"1","year":"1992","journal-title":"Human Mutation"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa010107","article-title":"IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation","volume":"349","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1210\/jc.2008-0509","article-title":"Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajhg.2012.08.005","article-title":"Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth","volume":"91","year":"2012","journal-title":"American Journal of Human Genetics"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/323266","article-title":"Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity","volume":"69","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198910123211501","article-title":"Laron dwarfism and mutations of the growth hormone-receptor gene","volume":"321","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","article-title":"Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome","volume":"52","year":"2015","journal-title":"Journal of Medical Genetics"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","year":"2002","journal-title":"American Journal of Human Genetics"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jc.2003-031033","article-title":"Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958\u20132003","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref121","first-page":"1236","article-title":"Is autosomal recessive Silver-Russel syndrome a separate entity or is it part of the 3-M syndrome spectrum?","volume":"155A","year":"2011","journal-title":"American Journal of Medical Genetics Part A"},{"key":"ref271","doi-asserted-by":"publisher","first-page":"2016174","DOI":"10.1530\/EJE-15-0937","article-title":"WitJMOostdijkWLosekootMvan Mechanisms in novel genetic causes of short stature of","journal-title":"endocrinology European Journal Endocrinology"},{"key":"ref171","first-page":"193","article-title":"The genetic aetiology of Silver-Russell syndrome","volume":"45","year":"2008","journal-title":"Journal of Medical Genetics"},{"key":"ref191","first-page":"215","article-title":"Noonan syndrome\u2014a new survey","volume":"13","year":"2017","journal-title":"Archives of Medical Science"},{"key":"ref371","first-page":"435","article-title":"Nine novel growth hormone receptor gene mutations in patients with Laron syndrome","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref141","first-page":"39","article-title":"The 3-M syndrome: a heritable low birthweight dwarfism","volume":"11","year":"1975","journal-title":"Birth Defects Original Article Series"},{"key":"ref211","first-page":"113","article-title":"Whole-exome sequencing in the differential diagnosis of primary adrenal insufficiency in children","volume":"6","year":"2015","journal-title":"Frontiers in Endocrinology"},{"key":"ref321","first-page":"29","article-title":"Diagnosis, genetics, and management of inherited bone marrow failure syndromes.","volume":"1","year":"2007","journal-title":"Hematology: American Society of Hematology. Education Program"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000338462","article-title":"Genetic analysis of short children with apparent growth hormone insensitivity","volume":"77","year":"2012","journal-title":"Hormone Research in Paediatrics"},{"key":"ref441","first-page":"139.e131","article-title":"3M syndrome: an easily recognizable yet underdiagnosed cause of proportionate short stature","volume":"161","year":"2012","journal-title":"Journal of Pediatrics"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/humu.21150","article-title":"OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels","volume":"31","year":"2010","journal-title":"Human Mutation"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000308164","article-title":"Acid-labile subunit deficiency and growth failure: description of two novel cases","volume":"73","year":"2010","journal-title":"Hormone Research in Paediatrics"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/2.4.355","article-title":"Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome","volume":"2","year":"1993","journal-title":"Human Molecular Genetics"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajhg.2009.04.021","article-title":"The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1","volume":"84","year":"2009","journal-title":"American Journal of Human Genetics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tem.2007.03.004","article-title":"Defects in growth hormone receptor signaling","volume":"18","year":"2007","journal-title":"Trends in Endocrinology and Metabolism: TEM"},{"key":"ref401","first-page":"444","article-title":"Clinical biochemical, and molecular investigations of a genetic isolate of growth hormone insensitivity (Laron\u2019s syndrome)","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000232486","article-title":"Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences","volume":"72","year":"2009","journal-title":"Hormone Research"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: clinical features, diagnosis, and management guidelines","volume":"126","year":"2010","journal-title":"Pediatrics"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ng1628","article-title":"Identification of mutations in CUL7 in 3-M syndrome","volume":"37","year":"2005","journal-title":"Nature Genetics"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1172\/JCI115071","article-title":"Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism","volume":"87","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2014.09.005","article-title":"The natural history of glycogen storage disease types VI and IX: long-term outcome from the largest metabolic center in Canada","volume":"113","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000334392","article-title":"The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway","volume":"76","year":"2011","journal-title":"Hormone Research in Paediatrics"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/177\/6\/EJE-17-0453.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-17-0453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:10:55Z","timestamp":1676373055000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/177\/6\/485\/6655294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":45,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1530\/eje-17-0453","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}